The ladder, priced step by step
The dual-agonist product page offers a series of options by month and week band, each with a stated milligram range and a stated surcharge, rising in five increments from the headline figure. A separate accelerated option carries a much larger surcharge.
It also lets a transferring patient pick the band closest to their current dose and prices each band, rather than restarting them at the bottom. That is a practical piece of publishing, and it is the reason this row is worth reading.
The consequence is that the headline figure is the cheapest a buyer will ever pay, not a typical one. We have recorded the surcharge ladder in the price qualifier so no page here can print the headline alone.
Fifty states, no molecule, no company
It states a service area in words — all fifty states and a territory — and runs a browsable store with a price against every product and a category filter.
Neither GLP-1 product names a molecule; both are sold as a class. Neither headline figure carries a billing period, even though the ladder is dated in weeks.
No operating company appears on the pages we read, including a fifty-two-thousand-character terms page. No compounding pharmacy or prescribing clinician is named. FDA issued it a warning letter in September 2025.
The HCG Institute's published pricing
| Medication | Price | Verified |
|---|---|---|
| Glp-1 (compounded) | $249⛔ NO PERIOD IS STATED and the molecule is not named: the store lists "GLP-1 Injections - Compounded $249.00" with no term beside it | September 2026source |
| Glp-1 (compounded) | $449⛔ "GLP-1 + GIP Injections - Compounded $449.00", and the product page adds a SIX-STEP SURCHARGE LADDER on top of it: "+$50.00" at weeks 5-8, "+$100.00" at weeks 9-12, "+$150.00" at weeks 13-16, "+$200.00" at weeks 17-20 and "+$250.00" from week 21, plus a "JumpStart" option at "+$800.00" | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 240 providers reviewed here are paid partners today; the other 236 are not. See how this works.
See The HCG Institute's current price →Good fit if
- Readers who want to know what a higher dose will add before they start.
- Transferring patients who want to enter at their current dose.
- Buyers who want a stated fifty-state service area.
Look elsewhere if
- Anyone who needs to know which molecule they are buying.
- Readers who want a billing period attached to the headline figure.
- Buyers who want the operating company named.
- People who need a named pharmacy or clinician.
How this review was verified
- Re-read the store index, the dual-agonist product page, the privacy policy and the terms on 7 September 2026, comparing requested to effective URLs with a nonsense path against the host in the same run, which returned a 404.
- Recorded the six-step surcharge ladder inside the price qualifier so the headline figure cannot be printed without it.
- Recorded both headline figures as carrying no period, because none is stated.
- Read the whole terms page for a corporate form and found none, so no entity is claimed here.
- Screened an exact phrase of the name against FDA’s live warning-letter datatable with both controls green, then re-fetched the letter: 200, title matching the name, the reference number and the date, against a minted nonsense letter path returning a 404 in the same run.